Philip (Phil) Powell Buys 50,000 Shares of INOVIQ Ltd (ASX:IIQ) Stock

INOVIQ Ltd (ASX:IIQ) insider Philip (Phil) Powell bought 50,000 shares of the firm’s stock in a transaction dated Monday, March 10th. The shares were purchased at an average price of A$0.35 ($0.22) per share, with a total value of A$17,500.00 ($11,075.95).

INOVIQ Price Performance

The firm has a market capitalization of $47.40 million, a price-to-earnings ratio of -6.02 and a beta of 2.04. The company has a debt-to-equity ratio of 2.02, a current ratio of 7.07 and a quick ratio of 9.52.

INOVIQ Company Profile

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample.